MSI-L

Clinical trials for MSI-L explained in plain language.

Never miss a new study

Get alerted when new MSI-L trials appear

Sign up with your email to follow new studies for MSI-L, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Three-Pronged attack on rectal cancer before surgery

Disease control Recruiting now

This study is testing a combination of three treatments given before surgery for locally advanced rectal cancer. The goal is to see if adding an immunotherapy drug (serplulimab) and an anti-inflammatory drug (celecoxib) to standard chemotherapy (CAPEOX) can shrink tumors more eff…

Matched conditions: MSI-L

Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control

Last updated Apr 02, 2026 05:11 UTC

MSI-L

Get alerted when new MSI-L trials appear

Three-Pronged attack on rectal cancer before surgery